Method for preparing remimazolam besylate with high efficiency
By employing sodium hypochlorite pentahydrate and alkaline earth metal peroxides with N-oxyl catalysts at room temperature, the synthesis of remimazolam besylate achieves high yield and reduced impurities, addressing the limitations of existing methods and improving the process's efficiency and safety for industrial production.
Patent Information
- Application Number
- PCT/KR2024/006939
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-11-28
- Filing Date
- 2024-05-22
- Publication Date
- 2024-11-28
AI Technical Summary
Existing methods for synthesizing remimazolam besylate face challenges such as low yield, high cost, safety concerns, and environmental impact due to the use of expensive and hazardous oxidizing agents, as well as the need for maintaining low temperatures and special equipment, which limits their suitability for industrial-scale production.
The use of sodium hypochlorite pentahydrate as an oxidizing agent in combination with alkaline earth metal peroxides and N-oxyl catalysts under mild conditions at room temperature, reducing the generation of impurities and increasing the oxidation conversion rate, thereby improving the efficiency and safety of the synthesis process.
This approach allows for a high-yield synthesis of remimazolam besylate with reduced impurities and improved stability, enabling efficient and cost-effective production without the need for low-temperature maintenance or hazardous reagents, thus enhancing the process's industrial viability.
Smart Images

Figure KR2024006939_28112024_PF_FP_ABST
Abstract
Description
High-efficiency remimazolam besylate manufacturing method
[0001] The present invention relates to a method for highly efficiently preparing remimazolam besylate. More specifically, the present invention provides a highly efficient method for synthesizing remimazolam besylate (structural formula P below) from commercially readily available 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propionic acid methyl ester (a compound of structural formula P-3 below) under mild reaction conditions and with improved overall yield compared to existing literature. More specifically, the present invention provides a method for preparing a compound of structural formula P by oxidizing a compound of structural formula P-3 below to a mixture of a compound of structural formula P-2 and a compound of structural formula P-1 through a novel oxidation reaction, and treating the mixture with benzene sulfonic acid.
[0002]
[0003] [Structural formula P]
[0004]
[0005] [Structural formula P-1]
[0006]
[0007] [Structural formula P-2]
[0008]
[0009] [Structural formula P-3]
[0010]
[0011] Remimazolam besylate is an imidazobenzodiazepine psychotropic drug developed by GlaxoSmithKline of the UK and Pion of Germany and is used as a sedative during surgical anesthesia. Compared to the existing propofol, it has a lower risk of cardiovascular depression and respiratory depression, and is safer for patients with renal and hepatic impairment, so it is attracting attention as a new anesthetic drug. Remimazolam besylate can be synthesized from 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propionic acid methyl ester of the structural formula P-3 below, which is readily available on the market, through two or three steps as shown in Scheme 1 below.
[0012]
[0013] [Reaction Formula 1]
[0014]
[0015]
[0016] An oxidation reaction for selectively oxidizing a secondary alcohol of a compound of structural formula P-3 to synthesize a compound of structural formula P-2 or a compound of structural formula P-1 or a mixture thereof is known as follows.
[0017] First, the oxidation reaction using the hypervalent iodine compound (1,1,1-triacetoxy-1,1-dihydro-1,2-benzoiodoxol-3(1H)-one (Dess-Martin periodinane)) of the structural formula (DM) presented in patent document 1 can obtain the compound of structural formula P-1 through the compound of structural formula P-2 in a yield of 76% and is also a good oxidizing agent in terms of purity (93.91%), but it has the disadvantage that Dess-Martin periodinane is an expensive reagent, is potentially explosive, and is not suitable for industrial-level production in terms of cost and safety because 1.5 times the equivalent of the reactant is used. In addition, the Swern oxidation using oxalyl chloride in dimethyl sulfoxide (DMSO) and the Albright-Goldman oxidation reagent (acetic anhydride / DMSO) presented in the document are sensitive to moisture and require reaction conditions of -60°C or lower. There are limitations in that it requires special production facilities because it must be maintained at ultra-low temperatures, and it is difficult to apply it to the production process due to the use of DMSO, which produces dimethyl sulfide, a gaseous byproduct, which has an odor and explosion risk and is difficult to process after the reaction.
[0018]
[0019] [Reaction Formula 2]
[0020]
[0021]
[0022] The oxidation reaction using chromium trioxide and sulfuric acid of the above reaction formula 2 described in patent document 2 can synthesize a compound of structural formula P-1 with high yield (90%) and purity (99.94%), but it has limitations in that it is difficult to apply to the process of the pharmaceutical industry because it uses sulfuric acid, a strong acid, and chromium trioxide, a heavy metal harmful to the human body and the environment.
[0023] As an alternative to these problems, Patent Documents 1, 3, and 4 propose a method for synthesizing a compound of structural formula P-2 by selectively oxidizing a secondary alcohol of a compound of structural formula P-3 using a combination of hypochlorite, an oxidizing agent that is economical, safe, and does not require special equipment, and an N-oxyl oxidation catalyst instead of an oxidizing agent that is harmful to the human body and the environment or expensive.
[0024] In Patent Document 1, a compound of structural formula P-2 was synthesized by selectively oxidizing a secondary alcohol of structural formula P-3 using sodium hypochlorite (NaOCl), tetramethylpiperidine-1-oxyl (hereinafter referred to as TEMPO), sodium bromide (NaBr), and sodium bicarbonate (NaHCO3), as shown in the following reaction scheme 3. The oxidation conversion rate for the reaction is not described and therefore unknown, but when benzene sulfonic acid was used to synthesize a compound of structural formula P from a compound of structural formula P-2 in a single step, the yield was described as 50%.
[0025]
[0026] [Reaction Formula 3]
[0027]
[0028]
[0029] Patent Document 3 describes that a compound of structural formula P-2 was synthesized from a compound of structural formula P-3 through a combination of sodium hypochlorite (NaOCl) and a catalytic amount of TEMPO, as shown in the following reaction scheme 4, and that the synthesis yield up to besylate was 58.43% (purity: 98.75%).
[0030]
[0031] [Reaction Formula 4]
[0032]
[0033]
[0034] In Patent Document 4, a compound of structural formula P-2 was synthesized from a compound of structural formula P-3 using 2-azaadamantane-N-oxyl (hereinafter referred to as AZADO) together with sodium hypochlorite (NaOCl) as shown in the following reaction scheme 5. The yield is unknown, and the oxidation conversion rate on HPLC is described as 99.9%. When the results were analyzed according to the test method 1 described in the examples below after conducting a direct experiment under the conditions, the oxidation conversion rate was low at 32.8% after 1 hour of stirring, and the reaction did not proceed any further even after stirring for 5 hours.
[0035]
[0036] [Reaction Formula 5]
[0037]
[0038]
[0039] The reactions of the above patent documents 1, 3, and 4 have the advantage of performing the oxidation reaction without special equipment using sodium hypochlorite (NaOCl), which is an economical and non-toxic oxidizing agent. However, they have the disadvantages of requiring long-term maintenance of low temperature, the need to perform the oxidation reaction under basic conditions of pH 8.6-9.5 by adding a base such as sodium bicarbonate (NaHCO3) and a salt such as sodium or potassium bromide for a smooth reaction, and these basic conditions increase the instability of the ester part of the compound, which increases side reactions and impurities. In addition, since sodium hypochlorite (NaOCl) is used in the form of an aqueous solution, which is more easily decomposed than the pentahydrate structure, quantitative analysis through titration is required before use, and due to the characteristics of the aqueous solution, the volumetric efficiency is lowered due to the sodium hypochlorite (NaOCl) content, which is generally up to 12-13 wt%, and the moisture content of the reaction solution inevitably increases, which increases the possibility of generating impurities.
[0040] As a result, when the final material, remimazolam, was synthesized from the compound of structural formula P-2 obtained in this way, the yield was low at less than 60%, and therefore, there is a need to study a more efficient process.
[0041] Conventional oxidation reactions using a combination of hypochlorite and N-oxyl oxidation catalysts (tetramethylpiperidine-1-oxyl (hereinafter referred to as TEMPO) or 2-azaadamantane-N-oxyl (hereinafter referred to as AZADO) or analogs thereof) as one of the oxidation reactions for obtaining a compound of structural formula P-2, which is a synthetic intermediate of remimazolam besylate (a compound of structural formula P), from a compound of structural formula P-3, are safe, economical, and can obtain the desired compound with good results.
[0042] However, these methods require low temperature maintenance, and as described in Patent Document 5, the reaction proceeds smoothly under basic conditions, so a base must be added to adjust the pH. However, under these basic conditions, the instability of not only the starting material but also the product increases due to the characteristics of remimazolam containing an ester group, which may generate a large number of impurities, which may result in a low synthetic yield to the final compound. In fact, the synthetic yield to the final compound described in Patent Documents 1 and 3 was low at less than 60%, and the synthetic yield of Patent Document 4 was not described, so when the results were confirmed according to Test Method 1 after conducting a direct experiment with reference to the patented method, the oxidation conversion rate was low at 32.8%.
[0043] The sodium hypochlorite (NaOCl) aqueous solutions used in the above documents have a maximum content of 13 wt%, which results in low volumetric efficiency and low ease of storage and use. Furthermore, sodium hypochlorite (NaOCl) in aqueous solution form is unstable, with its content continually decreasing, necessitating titration prior to use. This low storage stability and low volumetric efficiency present disadvantages in terms of long-term storage and industrial manufacturing, which require continuous use on a large scale. Furthermore, when using an aqueous solution, a large amount of water inevitably flows into the reaction solution, shifting the pH to 13, increasing the likelihood of impurities. A description of the characteristics of the above sodium hypochlorite (NaOCl) aqueous solution is provided in Non-Patent Document 1.
[0044]
[0045] Prior art literature
[0046] Patent documents
[0047] [Patent Document 1] KR 10-1801735 B
[0048] [Patent Document 2] KR 10-2021-0157146 A
[0049] [Patent Document 3] CN 112321594 B
[0050] [Patent Document 4] KR 10-2015-0120453 A
[0051] [Patent Document 5] KR 10-1162648 B
[0052]
[0053] Non-patent literature
[0054] [Non-patent Document 1] Organic Process Research & Development 2017 21 (12), 1925-1937
[0055] [Non-patent document 2] Molecules 2020, 25, 5918
[0056] The purpose of the present invention is to improve the limitations of the existing oxidation reaction in producing remimazolam besylate from a compound of structural formula P-3, thereby obtaining the final target compound (remimazolam besylate) in an economical, safe, highly efficient and high yield manner.
[0057] To address the above issues, the inventors of the present invention recognized the limitations of existing literature on synthesizing compounds of structural formula P-2 from compounds of structural formula P-3. To address these limitations, they studied oxidation reactions using economical, safe, and non-hazardous oxidants. Furthermore, by combining and adding catalysts that assist the oxidation reaction, they invented a significantly improved oxidation reaction, achieving rapid reaction completion at room temperature and reducing impurity formation compared to existing literature.
[0058] It is already known from various documents including Non-Patent Document 1 that sodium hypochlorite (NaOCl·5H2O) in pentahydrate form is superior to aqueous solution in terms of oxidation power, stability, ease of use, and volume efficiency. However, the present invention is the first to derive improved results by optimizing and verifying through various experiments for application to the actual manufacturing of remimazolam.
[0059] During the optimization process, alkaline earth metal peroxides and OXONE, which are economical, environmentally friendly, low-toxicity, and safe oxidants to assist the oxidation reaction, and ammonium salts, which are known as auxiliary catalysts for oxidation reactions through various literature including Non-patent Document 2, were combined and added in appropriate equivalent amounts to induce a safe oxidation reaction with high efficiency at low cost. The application of alkaline earth metal peroxides as catalysts in a similar oxidation reaction is novel in the present invention, and the reason for using alkaline earth metal peroxides is that increasing the amount of the oxidant (NaOCl·5H2O, AZADO, or OXONE) used in the present reaction does not proportionally increase the oxidation efficiency. Therefore, it is cost-effective to increase the oxidation efficiency by using a small amount of a catalyst that is less expensive than the above oxidants. In addition, alkaline earth metal peroxides are mild oxidants, which can improve the shortcomings of existing hypochlorite oxidants, such as the generation of impurities due to rapid oxidation and the necessity of maintaining a low temperature, while simultaneously inducing a reaction with a reduced reaction time and an improved yield. Calcium peroxide (CaO2) used in the examples of this reaction is an environmentally friendly ingredient also used as a material for toothpaste, so there is no burden in applying it to the process of the pharmaceutical industry.
[0060] The present invention was completed by conducting experiments to discover the combination and optimal amount of oxidizing agents to improve the reaction efficiency in the oxidation reaction of the present invention.
[0061] The above-described solution resulted in a reaction that was completed within 30 minutes at room temperature without the need for low-temperature maintenance, and resulted in improved purity and yield with reduced impurity generation. Furthermore, a compound of structural formula P-1, a key intermediate in the production of remimazolam besylate, was co-produced during the reaction, which then induced a favorable reaction for the synthesis of remimazolam besylate through a subsequent cyclization reaction.
[0062] According to the present invention, in the oxidation reaction of the compound of structural formula P-3, sodium hypochlorite pentahydrate (NaOCl·5H2O), which is an oxidizing agent in a form superior to an aqueous solution in terms of oxidizing power, economy, stability, volume efficiency, and ease of use, was used to improve the limitations of the existing reactions described above.
[0063] Unlike unstable sodium hypochlorite (NaOCl) aqueous solutions, sodium hypochlorite pentahydrate (NaOCl·5H2O) in the form of a pentahydrate has less content volatility, eliminating the inconvenience of having to titrate before use. In addition, it has excellent volume efficiency with a content of up to 44 wt% compared to the aqueous solution, which had a maximum content of 12-13 wt%. The above advantages, including storage stability and volume efficiency, are very important from an industrial manufacturing perspective that requires long-term storage and continuous use in large quantities.
[0064] In addition, when using sodium hypochlorite (NaOCl) aqueous solution, a large amount of water is inevitably added to the reaction solution, forming a basic environment with a pH of 13. However, when replaced with sodium hypochlorite pentahydrate (NaOCl·5H2O), the water content of the reaction solution is significantly reduced and the pH also decreases to 11. As the conditions change to relatively mild conditions, the possibility of generating impurities is reduced, so there is no need to maintain a low temperature during the reaction, and reaction conditions having a higher oxidation conversion rate and target compound production rate have been invented.
[0065] In addition, by adding alkaline earth metal peroxide substances, which are mild oxidizers that are economical, environmentally friendly, and have low human toxicity, as auxiliary oxidizers and discovering their appropriate usage amount, a mild oxidation reaction with high efficiency at low cost was induced.
[0066] In order to find the amount of calcium peroxide (CaO2), one of the alkaline earth metal peroxides, used in the examples of the main text, an experiment was conducted to find the amount that yields the maximum efficiency. As a result, it was shown that the oxidation conversion rate was clearly improved at a certain equivalent amount, rather than a proportional increase according to the amount added. In fact, as a result of a comparative experiment and optimization of the amount according to the presence or absence of calcium peroxide (CaO2) added under the same conditions, it was confirmed that the production rate of the target compound increased by more than 9% at a certain point. This indicates that calcium peroxide (CaO2) is suitable as a catalyst when used in the equivalent amount suggested by the inventors in the reaction of the present invention.
[0067] By appropriately combining and using the above-mentioned sodium hypochlorite pentahydrate (NaOCl·5H2O), calcium peroxide (CaO2), OXONE, ammonium salt, and N-oxyl oxidation catalyst, an oxidation conversion rate of 98.9% is reached within 30 minutes at room temperature without the need for low-temperature maintenance and pH control, which were limitations of existing inventions. Since basic conditions are not required, the instability of the ester group constituting the compound is resolved and impurities are reduced, so that the target compound can be manufactured with high purity and high yield without purification.
[0068] One of the important effects of the above combination is that the compound of structural formula P-1, which is an important intermediate in the production of remimazolam besylate, is produced together during the reaction, which is advantageous for the synthesis of remimazolam besylate through a subsequent cyclization reaction. In the examples of hypochlorite / N-oxyl oxidant conditions of patent documents 1 and 4, which are comparable to the present invention, it is stated that only the compound of structural formula P-2 is provided, whereas the examples of the present invention provide the compound of structural formula P-1 at a high ratio of the compound of structural formula P-2:the compound of structural formula P-1, up to about 2:98.
[0069] When the product obtained according to the conditions of the present invention was synthesized up to remimazolam besylate, the yield for the two steps was increased by 1.6 to 1.9 times or more compared to existing literature, thereby completing the present invention.
[0070] Figure 1 shows the results of HPLC analysis of the reaction solution after 30 minutes of stirring in Example 3-3. The peak areas of the compound of structural formula P-2 shown at 8.925 minutes and the compound of structural formula P-1 shown at 11.771 minutes account for 91.5% of the total peak area, and the ratio of each is 41:59, indicating that the compound of structural formula P-1 is produced in greater quantities. The compound of structural formula P-3 shown at 8.464 minutes was produced in small amounts of 1.06%, and other impurities were produced in small amounts of 7.4%.
[0071] Figure 2 shows the analysis of remimazolam besylate obtained in Example 4 through HPLC. The purity of remimazolam besylate, indicated at 12.553 minutes, is 98.49%.
[0072] Figure 3 is a graph comparing the results of Comparative Example 1 and Example 1 by temperature.
[0073] Figure 4 is a graph showing the target compound production rate of Comparative Example 1 and Example 1 conducted at 15°C according to reaction time.
[0074] Figure 5 is a graph showing the target compound production rate of Comparative Example 1 and Example 1 conducted at room temperature according to reaction time.
[0075] Hereinafter, the present invention will be described in detail.
[0076] The present invention provides a process for preparing remimazolam besylate (structural formula P), comprising the steps of: (a) oxidizing 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propionic acid methyl ester (optionally an alcohol group) of structural formula P-3 together with a hydrate of hypochlorite, an N-oxyl oxidation catalyst, an ammonium salt and an inorganic oxidizing agent in the presence of an organic solvent; and (b) treating the reaction product obtained in step (a) with benzene sulfonic acid in an organic solvent or a mixture of organic solvents. In this case, the reaction product obtained in step (a) is a mixture of structural formulas (P-1) and (P-2).
[0077]
[0078] [Structural formula P-3]
[0079]
[0080] [Structural formula P-2]
[0081]
[0082] [Structural formula P-1]
[0083]
[0084] [Structural formula P]
[0085]
[0086]
[0087] The compound of the above structural formula P-3 is readily available commercially and can be synthesized according to the method described in Patent Document 1.
[0088] The reaction of the above step (a) is a reaction of oxidizing a compound of structural formula P-3 in the presence of an organic solvent together with a hydrate of hypochlorite and an N-oxyl oxidation catalyst. The above step a) may additionally use an ammonium salt, an inorganic oxidizing agent, or a peroxide of an alkaline earth metal. The above reaction conditions are conditions in which the oxidizing agent oxidizes a secondary alcohol to a ketone to produce P-2 without reacting with other functional groups of the compound of structural formula P-3, and at the same time, some compounds of structural formula P-2 undergo cyclization under the reaction conditions and are converted to compounds of structural formula P-1.
[0089] As a result, the product of step (a) may be a mixture of a compound of structural formula P-2 and a compound of structural formula P-1.
[0090] The compound of structural formula P-1 and the compound of structural formula P-2 can be separated by a method generally used in organic synthesis technology, but the product (mixture) of step (a) can proceed to step (b) without purification after work-up, and since the cyclization to the compound of structural formula (P-1) and the synthesis of remimazolam besylate of structural formula P are performed in a single step under acid conditions in step (b), the production of the compound of structural formula P-1 is advantageous in the synthesis of the final compound.
[0091] For the purpose of the present invention, it is preferable to terminate the reaction when the compound of structural formula P-3 is consumed by 90% or more, preferably 95% or more, more preferably 98% or more, and the impurity production rate is 10% or less, preferably 6% or less.
[0092] The above reaction is completed within 15 minutes of stirring and within 180 minutes, more preferably within 40 minutes, and most preferably within 20 minutes of stirring and within 35 minutes to obtain the product of the highest purity.
[0093] The above reaction can be performed at room temperature (0°C-30°C) without any special temperature setting, and is most preferably performed at 20°C-25°C, considering the oxidation conversion rate and the possibility of generating impurities.
[0094] The oxidizing agent of the above step (a) is a hydrate of hypochlorite, and may be one selected from the group consisting of a hydrate of sodium hypochlorite (NaOCl), a hydrate of potassium hypochlorite (KOCl), and a hydrate of calcium hypochlorite (Ca(OCl)2), and, if required, a mixture obtained by mixing the above-described oxidizing agents.
[0095] Among the above oxidizing agents, it is preferable to specifically use sodium hypochlorite pentahydrate (NaOCl·5H2O).
[0096] The above oxidizing agent can be used in an equivalent ratio of 0 to 10, preferably 0.1 to 5, with respect to the compound of structural formula P-3.
[0097] Depending on the form of sodium hypochlorite used in the above reaction, the reaction pattern shows differences. When sodium hypochlorite pentahydrate (NaOCl·5H2O) was used, a higher oxidation conversion rate was observed in the above reaction compared to a sodium hypochlorite (NaOCl) aqueous solution (12-14 wt%), and the degree of impurity generation was also significantly reduced.
[0098] The N-oxyl oxidation catalyst of the above step (a) is 2,2,6,6,-tetramethylpiperidine N-oxyl (TEMPO) and its 4-substituted derivatives including 4-methoxy-TEMPO, 4-ethoxy-TEMPO, 4-acetoxy-TEMPO, 4-acetamino-TEMPO, 4-hydroxy-TEMPO, 4-benzoyloxy-TEMPO, 4-amino-TEMPO, N,N-dimethylamino-TEMPO, 4-oxo-TEMPO and poly[(6-[1,1,3,3-tetramethylbutyl)amino]-s-triazine-2, 4-diyl(4-diyl)], also known as Chimasorb 944. A polymeric version of TEMPO such as [(2,2,6,6-tetramethyl-4-piperidyl)imino]hexamethylene[2,2,6,6-tetramethyl-4-piperidinyl)imino]], a compound represented by 2-azaadamantane-N-oxyl (AZADO), 1-methyl-2-azaadamantane-N-oxyl (Me-AZADO), 2-hydroxy-2-azaadamantane (AZADOH), Nor-AZADO, ABNO, a salt thereof, a solvate thereof, and a mixture obtained by mixing the above-mentioned catalysts, if desired.
[0099] The above N-oxyl oxidation catalyst is preferably one selected from among AZADO, Me-AZADO, AZADOH, Nor-AZADO, TEMPO, and ABNO, and more specifically, AZADO, Me-AZADO, and ABNO are most preferred.
[0100] The above N-oxyl oxidation catalyst can be used in an equivalent ratio of 0.001 to 1, preferably 0.01 to 0.2, with respect to the compound of structural formula P-3.
[0101] The structure of the compound represented by 2-azaadamantane-N-oxyl (AZADO) used in the present invention is as shown in the following structural formula 1.
[0102] [Structural formula 1]
[0103]
[0104]
[0105] The structure of the compound represented by 1-methyl-2-azaadamantane-N-oxyl (Me-AZADO) used in the present invention is as shown in the following structural formula 2.
[0106] [Structural formula 2]
[0107]
[0108]
[0109] The structure of the compound represented by 2-hydroxy-2-azaadamantane (AZADOH) used in the present invention is as shown in the following structural formula 3.
[0110] [Structural formula 3]
[0111]
[0112]
[0113] The structure of the compound represented by 2,2,6,6-tetramethylpiperidine N-oxyl (TEMPO) used in the present invention is as shown in the following structural formula 4.
[0114] [Structural formula 4]
[0115]
[0116]
[0117] The structure of the compound represented by 9-azabicyclo-[3.3.1]nonane-N-oxyl (ABNO) used in the present invention is as shown in the following structural formula 5.
[0118] [Structural formula 5]
[0119]
[0120]
[0121] The ammonium salt assisting the oxidation reaction of the above step (a) may be one selected from the group consisting of compounds represented by tetrabutylammonium bromide (TBAB), tetrabutylammonium fluoride (TBAF), tetrabutylammonium chloride (TBAC), tetrabutylammonium iodide (TBAI), salts thereof, and solvates thereof, and preferably may be tetrabutylammonium bromide (TBAB).
[0122] The above ammonium salt can be used in an equivalent ratio of 0.001 to 10, preferably 0.01 to 0.5, and most preferably 0.01 to 0.2, with respect to the compound of structural formula P-3.
[0123] The alkaline earth metal peroxide assisting the oxidation reaction of the above step (a) may be one selected from the group consisting of compounds represented by calcium peroxide (CaO2), magnesium peroxide (MgO2), salts thereof, and solvates thereof, and preferably may be calcium peroxide (CaO2).
[0124] The above alkaline earth metal peroxide can be used in an equivalent ratio of 0 to 1, preferably 0.01 to 0.5, and most preferably 0.05 to 0.2, with respect to the compound of structural formula P-3.
[0125] The reaction of the above step (a) shows differences depending on whether calcium peroxide (CaO2) is added or not. When calcium peroxide (CaO2) is added, the production rate of the target compound increases compared to the reaction without addition.
[0126] The oxidation conversion rate and the production rate of the target compound differ depending on the amount of calcium peroxide (CaO2) added. When calcium peroxide (CaO2) was added at 0.037 equivalent (3.7 mol%) / 0.075 equivalent (7.5 mol%) / 0.1 equivalent (10 mol%) / 0.15 equivalent (15 mol%), the optimal result was obtained at 0.1 equivalent (10 mol%), and the oxidation conversion rate decreased when it was used more than necessary. In addition, the production rate of the compound of structural formula P-1 was the highest at that point. This shows that there is an optimal amount to use when using calcium peroxide (CaO2) as a catalyst for a mild oxidation reaction, and it is an important factor to discover this amount and apply it to the reaction.
[0127] The inorganic oxidizing agent assisting the reaction of the above step (a) may be one selected from the group consisting of a commercially available compound represented by OXONE (2KHSO5.KHSO4.K2SO4), a salt thereof, and a solvate thereof.
[0128] The above inorganic oxidizing agent can be used in an equivalent ratio of 0.1 to 10, preferably 0.01 to 3, with respect to the compound of structural formula P-3.
[0129] The organic solvent of the above step (a) may be one selected from the group consisting of ethyl acetate, methyl acetate, methylene chloride, dichloroethane, toluene, acetone, diethyl ether, methyl tert-butyl ether, pentane, hexane, acetonitrile, and tetrahydrofuran, and is a mixture obtained by mixing the above-described solvents when required.
[0130] The above organic solvent is preferably at least one selected from among ethyl acetate, methylene chloride, acetonitrile, and tetrahydrofuran, and more specifically, excellent results are obtained from acetonitrile.
[0131] In the present invention, the word "work-up" in "the product (mixture) of step (a) can proceed to step 2) without purification after work-up" means a general work-up operation performed with an aqueous solution and an organic solvent for reaction quenching and washing in organic synthesis. In the above reaction, washing and reaction quenching are induced using an aqueous solution of sodium thiosulfate and ethyl acetate, and the separated organic layer is extracted and dried to proceed to step (b).
[0132] In the preparation of remimazolam besylate (a compound of structural formula P), the concentrated residue obtained after the work-up in step (a) can be prepared without performing purification such as distillation, silica gel chromatography, or recrystallization. This is because the oxidation reaction in step (a) proceeds at a remarkably high conversion rate with good reproducibility.
[0133]
[0134] After performing the reaction of the above step (a), the reaction of step (b) is a step of producing remimazolam besylate (a compound of structural formula P) by reacting the concentrated residue obtained in the above step (a) with an organic acid in the presence of an organic solvent.
[0135] The reaction of the above step (b) is a one-pot reaction comprising a step of converting a compound of structural formula P-2 to a compound of structural formula P-1 by cyclization, and a step of forming a salt of the compound of structural formula P-1 that is converted or exists as a product of step (a) to synthesize remimazolam besylate of structural formula P.
[0136] The organic acid of the above step (b) may be one selected from the group consisting of benzene sulfonic acid, a salt thereof, a hydrate thereof, and a solvate thereof.
[0137] The above organic acid can be used in an equivalent ratio of 0.9 to 2, preferably 0.9 to 1.3, with respect to the compound of structural formula P-3.
[0138] The reaction of step (b) above can be performed at 0°C to 100°C, preferably 20°C to 50°C, for 1 hour to 72 hours, preferably 24 hours to 48 hours.
[0139] The organic solvent of the above step (b) may be one selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, n-butyl alcohol, t-butyl alcohol, ethyl acetate, methyl acetate, methylene chloride, acetonitrile, and methyl ethyl ketone, and may be a mixture obtained by mixing the above-described solvents, if required.
[0140] It is preferable that the above organic solvent is specifically one selected from methanol, ethanol, and ethyl acetate, or a mixture thereof.
[0141] The remimazolam besylate (compound of structural formula P) produced during the reaction of the above step (b) can be separated by a method generally used in organic synthesis, and can be produced as a crystal from the reaction mixture during the reaction or separated by crystallization from one selected from methanol, ethanol, and ethyl acetate, or a mixture thereof.
[0142]
[0143] Example
[0144]
[0145] Information on the main reagents used in the examples is as follows.
[0146]
[0147] Sodium hypochlorite (NaOCl) aqueous solution (hereinafter referred to as NaOCl aqueous solution)
[0148] Manufacturer: Sigma-aldrich, Content: 10-15 wt%
[0149] Sodium hypochlorite pentahydrate (hereinafter referred to as NaOCl·5H2O)
[0150] Manufacturer: WAKO, Content: 39%
[0151] Calcium peroxide (CaO2)
[0152] Manufacturer: Sigma-aldrich, Purity: 75%
[0153] 2-Azaadamantane-N-oxyl (hereinafter referred to as AZADO)
[0154] Manufacturer: Sigma-Aldrich, Purity: 90%
[0155] OXONE
[0156] Manufacturer: TCI, Purity: >Ca.45%(T) as KHSO5
[0157] Tetrabutylammonium bromide (hereinafter referred to as TBAB)
[0158] Manufacturer: JUNSEI, Purity: 98%
[0159] Benzene sulfonic acid
[0160] Manufacturer: Sigma-Aldrich, Purity: 90%
[0161]
[0162] HPLC analysis of the examples in the text was performed under the following conditions.
[0163]
[0164] HPLC conditions
[0165] Column: YMC ODS-AQ, 250 x 4.6 mm, 3 μm particle size
[0166] Moving
[0167] Mobile phase A: 0.01% trifluoroacetic acid in water
[0168] Mobile phase B: 0.01% trifluoroacetic acid in acetonitrile
[0169] gradient:
[0170]
[0171]
[0172] Flow rate: 1.0 mL / min
[0173] Column temperature: 40℃
[0174] Autosampler: Ambient
[0175] Detection: UV at 230 nm
[0176] Injection volume: 10 μl
[0177] Running time: 40 minutes
[0178]
[0179] Under the conditions described above, the retention time of the compound of structural formula P-3 is about 8.4 minutes, the retention time of the compound of structural formula P-2 is about 9.2 minutes, and the retention times of the compound of structural formula P-1 and remimazolam besylate are the same, about 11.9 minutes.
[0180] The oxidation conversion rate and target compound production rate used to derive the results of the examples were calculated according to the methods described in Test Method 1 and Test Method 2 below.
[0181]
[0182] Test Method 1: Calculation of Oxidation Conversion Rate
[0183] [Calculation Formula 1]
[0184]
[0185]
[0186] The oxidation conversion rate is a value calculated according to [Calculation Formula 1] and is a value predicted through HPLC as a percentage of the ratio of the starting material and the target compound in the reaction solution, without considering impurities.
[0187] A(P-3) represents the peak area of the compound of structural formula P-3;
[0188] A(P-2) represents the peak area of the compound of structural formula P-2;
[0189] A(P-1) represents the peak area of the compound of structural formula P-1.
[0190]
[0191] Test Method 2: Calculation of Target Compound Production Rate
[0192] [Calculation Formula 2]
[0193] 100 X {A(P-2) + A(P-1)} / Integral value of all peak areas including impurities
[0194] The target compound production rate is the value calculated according to [Calculation Formula 2] and is the percentage value of the actual target compound present in the reaction solution predicted through HPLC.
[0195] In the above calculation formula, A represents the peak area of each compound in HPLC using the method described below.
[0196] A(P-2) represents the peak area of the compound of structural formula P-2;
[0197] A(P-1) represents the peak area of the compound of structural formula P-1.
[0198]
[0199] Test Method 3: P-2:P-1 Ratio Calculation Method
[0200] [Calculation Formula 3]
[0201]
[0202]
[0203] The P-2:P-1 ratio is a value calculated according to [Calculation Formula 3] and is a value predicted through HPLC of the ratio of the compound of structural formula P-2 to the compound of structural formula P-1 among the target compounds (compound of structural formula P-2 and compound of structural formula P-1) generated during the reaction.
[0204] In the above calculation formula, A represents the peak area of each compound in HPLC using the method described below.
[0205] A(P-2) represents the peak area of the compound of structural formula P-2;
[0206] A(P-1) represents the peak area of the compound of structural formula P-1.
[0207]
[0208] Comparative Example 1
[0209] Comparative Example 1 shows a comparative oxidation reaction experiment conducted at various temperatures using the method described in Patent Document 4 (KR 10-2015-0120453 A) applied for by Pion, Germany, but was rejected.
[0210] Comparative Example 1-1: Same experiment as Example 3-1 of Patent Document 4
[0211] A compound of structural formula P-3 (100 mg, 0.22 mmol) was suspended in a mixed solution of 0.77 mL of methyl acetate and 1.3 mL of toluene. To the reaction mixture were added a 14 wt% aqueous sodium hypochlorite solution (0.12 mL, 0.26 mmol), AZADO (0.112 mg, 0.00066 mmol), 0.41 mL of an aqueous sodium hydrogen carbonate solution (7.7 wt%), and potassium bromide (1.31 mg, 0.011 mmol), and the mixture was stirred at 0°C for 1 hour. Thereafter, the oxidation conversion and the target compound were determined using HPLC according to Test Methods 1 and 2 described above, respectively.
[0212]
[0213] Comparative Example 1-2: Experiment of Example 3-1 of Patent Document 4 at 15°C
[0214] A compound of structural formula P-3 (500 mg, 1.1 mmol) was suspended in a mixed solution of 3.9 mL of methyl acetate and 6.5 mL of toluene. To the reaction mixture were added a 14 wt% aqueous sodium hypochlorite solution (0.6 mL, 1.3 mmol), AZADO (0.56 mg, 0.0033 mmol), 2.1 mL of an aqueous sodium hydrogen carbonate solution (7.7 wt%), and potassium bromide (6.6 mg, 0.055 mmol), and the mixture was stirred at 15°C for 24 hours. The reaction solutions were analyzed by HPLC at 5 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 5 hours, 7 hours, and 24 hours after the start of the reaction, and the oxidation conversion and the target compound were calculated according to Test Methods 1 and 2 described above, respectively. The results of the time with the highest target compound production rate among the HPLC results for each hour are shown in Graph 1 below.
[0215] Comparative Example 1-3: Experiment of Example 3-1 of Patent Document 4 at room temperature
[0216] The same method as Comparative Example 1-2 was used except that the reaction temperature was changed to room temperature (25-30°C).
[0217] Comparative Example 1-4: Experiment of Example 3-1 of Patent Document 4 at 40°C
[0218] The same method as Comparative Example 1-2 was used except that the reaction temperature was changed to 40°C.
[0219] Comparative Example 1-5: Experiment of Example 3-1 of Patent Document 4 at 50°C
[0220] The same method as Comparative Example 1-2 was used except that the reaction temperature was changed to 50°C.
[0221] Comparative Example 1-6: Experiment of Example 3-1 of Patent Document 4 at 60°C
[0222] The same method as Comparative Example 1-2 was used except that the reaction temperature was changed to 60°C.
[0223]
[0224] Example 1: Comparison of reaction patterns when sodium hypochlorite aqueous solution is replaced with sodium hypochlorite pentahydrate.
[0225] Example 1 demonstrates that the use of sodium hypochlorite in hydrate form rather than in aqueous solution is more effective in the present oxidation reaction by conducting an experiment using sodium hypochlorite pentahydrate as in Comparative Example 1.
[0226]
[0227] Experiment of Example 1-1: The experiment was performed in the same manner as in Comparative Example 1-1, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0228] Experiment of Example 1-2: The experiment was performed in the same manner as in Comparative Example 1-2, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0229] Experimental Example 1-3: The experiment was performed in the same manner as in Comparative Example 1-3, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0230] Experimental Example 1-4: The experiment was performed in the same manner as in Comparative Example 1-4, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0231] Experimental Example 1-5: The experiment was performed in the same manner as in Comparative Example 1-5, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0232] Experimental Example 1-6: The experiment was performed in the same manner as in Comparative Example 1-6, except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate.
[0233]
[0234] The results of Comparative Example 1 and Example 1 were compared by temperature and shown in Graph 1 of Fig. 3.
[0235] Graph 1 shows that Example 1 has better results in all temperature ranges from 0℃ to 60℃. Example 1 shows the optimal result of over 90% target compound production rate between 25℃ and 40℃, which is the temperature range corresponding to general room temperature, indicating that room temperature reaction is possible without separate temperature control equipment. On the other hand, the experimental results of Comparative Example 1 showed that the target compound production rate was low at 30-40% in most temperature ranges. Among these, the optimal temperature is 15℃, and since Patent Document 4 (KR 10-2015-0120453 A) also maintains a low temperature of 0℃ to carry out Comparative Example 1, it can be seen that a separate low-temperature maintenance device is required to use sodium hypochlorite in the form of an aqueous solution in this reaction.
[0236]
[0237] The target compound production rates of Comparative Example 1 and Example 1, which were carried out at two temperatures (15℃, room temperature), were plotted according to the reaction time (Graph 2 in FIG. 4 and Graph 3 in FIG. 5). In Comparative Example 1-3, which used a sodium hypochlorite aqueous solution, the target compound production rate at room temperature rapidly decreased within 2 hours, whereas in Example 1-3, which used sodium hypochlorite hydrate, the product was maintained for more than 24 hours. In Comparative Example 1-2, which was carried out at a lower temperature of 15℃, the product retention time was longer than in Comparative Example 1-3, but the product began to decrease after 7 hours, whereas in Example 1-2, the product was maintained for more than 24 hours. This shows that when sodium hypochlorite is used as an aqueous solution in this oxidation reaction, low temperature maintenance is essential to maintain the product, whereas when it is used as a hydrate, the product is stably maintained even at room temperature.
[0238]
[0239] Example 2: Oxidation reaction using calcium peroxide (CaO2) / OXONE / TBAB complex
[0240] Example 2 is an experiment showing that the calcium peroxide (CaO2) / OXONE / TBAB complex is effective as a cocatalyst in the AZADO / hypochlorite oxidation reaction.
[0241]
[0242] Experiment of Example 2-1: The experiment was performed under similar conditions as Comparative Example 1-3, except that the calcium peroxide (CaO2) / OXONE / TBAB complex was added.
[0243] 14 wt% sodium hypochlorite aqueous solution (0.16 mL, 0.264 mmol) and AZADO (0.84 mg, 0.005 mmol) were added to 3 mL of acetonitrile, and stirred at room temperature for 1 to 2 minutes. P-3 (100 mg, 0.22 mmol), OXONE (298 mg, 0.484 mmol), TBAB (11.2 mg, 0.035 mmol), and calcium peroxide (CaO2) (1.59 mg, 0.016 mmol) were added to the reaction mixture, and stirred at room temperature for 30 minutes. Thereafter, the oxidation conversion rate and the target compound production rate were determined using HPLC according to Test Methods 1 and 2 described above, respectively.
[0244] Oxidation conversion rate: 75.3% / Target compound production rate: 55.9%
[0245] Experimental Example 2-2: A similar method to Example 2-1 was performed except that the 14 wt% sodium hypochlorite aqueous solution was replaced with the same molar amount of sodium hypochlorite pentahydrate, and the oxidation conversion rate and the target compound production rate were determined according to Test Methods 1 and 2 described above, respectively.
[0246] Oxidation conversion rate: 98.2% / Target compound production rate: 94.3%
[0247] [Table 1]
[0248]
[0249]
[0250] The above [Table 1] shows that the response is improved when sodium hypochlorite pentahydrate and the complex (CaO2 / OXONE / TBAB) are used.
[0251] The results of Example 1-3 and Example 2-2, in which the sodium hypochlorite aqueous solution of Comparative Example 1-3 and Example 2-1 was replaced with a pentahydrate, showed that the target compound production rate increased by approximately 4.8 times and 1.7 times, respectively, showing that sodium hypochlorite pentahydrate is more effective than the aqueous solution in the present oxidation reaction.
[0252] The results of Example 2-1 and Example 2-2, in which the production rate of the target compound increased by approximately 3 times and 1.2 times, respectively, by adding the complex agent to the conditions of Comparative Example 1-3 and Example 1-3, show that the oxidation reaction is improved by adding the complex agent.
[0253]
[0254] Example 3: Study on the effect of calcium peroxide (CaO2) addition amount
[0255] Experiment 3-1: No addition of calcium peroxide (CaO2)
[0256] The same method as Example 2-2 was performed except that calcium peroxide (CaO2) was not added, and the oxidation conversion rate and target compound production rate were determined according to Test Methods 1 and 2 described above, respectively.
[0257]
[0258] Experimental Example 3-2: Using 3.7 mol% calcium peroxide (CaO2)
[0259] The same method as Example 2-2 was performed except that the amount of calcium peroxide (CaO2) used was changed to (3.7 mol%, 0.0082 mmol, 0.79 mg), and the oxidation conversion rate and target compound production rate were determined according to Test Methods 1 and 2 described above, respectively.
[0260]
[0261] Experiment 3-3: Using 10 mol% calcium peroxide (CaO2)
[0262] The same procedure as Example 2-2 was followed except that the amount of calcium peroxide (CaO2) used was changed to (10 mol%, 0.022 mmol, 2.11 mg), and the oxidation conversion rate and the target compound production rate were determined according to Test Methods 1 and 2 described above, respectively. Afterwards, an aqueous solution of sodium thiosulfate was added to the reaction mixture, and it was separated into layers. The organic layer thus obtained was washed with an aqueous solution of ammonium chloride. The organic layer obtained was dried over anhydrous sodium sulfate and filtered, and the filtrate was concentrated under reduced pressure.
[0263]
[0264] Experimental Example 3-4: Using 15 mol% calcium peroxide (CaO2)
[0265] The same method as Example 2-2 was performed except that the amount of calcium peroxide (CaO2) used was changed to (15 mol%, 0.033 mmol, 3.17 mg), and the oxidation conversion rate and target compound production rate were determined according to Test Methods 1 and 2 described above, respectively.
[0266]
[0267] The results of Examples 3-1 to 3-4 were compared with the results of Example 2-2 and are shown in Table 2 below.
[0268] [Table 2]
[0269]
[0270]
[0271] From the results in Table 2 above, it was confirmed that the oxidation conversion rate and target compound production rate were the lowest when calcium peroxide (CaO2) was excluded (Example 3-1). This confirmed that calcium peroxide (CaO2) not only induces a stable oxidation reaction in this oxidation reaction but also reduces the production of impurities.
[0272] However, this oxidation efficiency did not increase proportionally to the equivalent of calcium peroxide (CaO2), but showed maximum efficiency when an appropriate amount was used, and the ratio of P-1 generated during the reaction also varied depending on the equivalent of calcium peroxide (CaO2). It was confirmed that when it was about 10 mol% (Example 3-3), the oxidation reaction was converted to the maximum and the ratio of P-1 was also the maximum.
[0273]
[0274] Example 4: Synthesis of remimazolam besylate from the product of Example 3-3
[0275] Benzene sulfonic acid (38.3 mg, 0.24 mmol), a mixed solvent of methanol and ethyl acetate (mixing ratio: 1:30) were added to the concentrated residue of Example 3-3, and the mixture was stirred at room temperature overnight. The reaction mixture was filtered with 100% ethyl acetate, and the obtained solid was dissolved in methanol. Activated carbon (30 mg) was added, stirred at room temperature for 2 hours, and then filtered. The filtrate was redissolved in a mixed solvent of MeOH and EA (mixing ratio: 1:10), and stirred at room temperature overnight. The precipitated crystals were filtered and washed to obtain 124.3 mg of remimazolam besylate (P). (Yield: 95%, Purity: 98.49%) The obtained remimazolam besylate was analyzed by HPLC and is shown in Figure 2 below.
[0276]
[0277] Example 5: Oxidation reaction using ABNO
[0278] Example 5 demonstrates that various N-oxyl oxidation catalysts can be used in the present oxidation reaction by using ABNO, which has a similar function, instead of AZADO.
[0279]
[0280] Experimental Example 5-1: Sodium hypochlorite pentahydrate (2.7 g, 16.3 mmol) was suspended in 90 mL of tetrahydrofuran. ABNO (96.4 mg, 0.65 mmol) and a compound of structural formula P-3 (3.0 g, 6.5 mmol) were added to the reaction mixture, and the mixture was stirred at room temperature for 1 hour. The oxidation conversion and the target compound production rate were determined using HPLC according to Test Methods 1 and 2 described above, respectively. Afterwards, 90 mL of a 20% sodium thiosulfate aqueous solution was added, and the mixture was stirred for 30 minutes. Afterwards, 45 mL of ethyl acetate was additionally added, and the mixture was stirred for 30 minutes. The separated organic layer was extracted using a separatory funnel, dried over sodium sulfate, and concentrated in a reduced pressure evaporator.
[0281] Oxidation conversion rate: 99.1% / Target compound production rate: 98.0%
[0282]
[0283] Experimental Example 5-2: Synthesis of remimazolam besylate from the product of Example 5-1
[0284] To the concentrated residue of Example 5-1, benzene sulfonic acid (516 mg, 3.3 mmol) and 18 mL of a mixed solvent of ethanol and ethyl acetate (mixing ratio 1:5) were added, and the mixture was stirred at room temperature overnight. The precipitated solid was filtered and washed with the same solvent as the reaction solvent, obtaining 1.57 g of remimazolam besylate (P). (Yield: 81%, Purity: 98%)
[0285]
[0286] [Table 3]
[0287]
[0288]
[0289] Table 3, which compares the experiments (Comparative Example 1-1) of existing literature comparable to the present invention and Examples 1-3, 3-3, and 5-1, demonstrates that the oxidation efficiency and reaction conditions of the present invention are significantly improved by using sodium hypochlorite pentahydrate. The effectiveness of the complex agent can be explained by the absence of the need for low-temperature maintenance and pH control, and the fact that the target compound production rate increases by more than three times within a reaction time of 30 minutes.
[0290] In addition, the compound ratio of structural formula P-1 calculated according to Test Method 3 is superior to that of Comparative Example 1-1, which is more advantageous in the synthesis of remimazolam besylate through the subsequent step of cyclization. The ratio of P-2:P-1 and the degree of impurity generation according to Test Method 3 of the reaction solution of Example 3-3 were analyzed through HPLC and are shown in Figure 1 below.
[0291]
[0292] [Table 4]
[0293]
[0294]
[0295] Examples 4 and 5-2 show that when remimazolam besylate was synthesized from the products synthesized according to Examples 3-3 and 5-1, which are the optimal conditions of the present invention, the overall yield was significantly increased compared to that in the literature. The results in Table 4 above show the purification yields for the two steps of preparing remimazolam besylate from the compound of structural formula P-3, and the results of Patent Document 1 and Patent Document 3 refer to the yields described in the literature. Since the results of Patent Document 4 were unknown, we conducted an experiment ourselves, but the yield was low in the oxidation step (oxidation conversion rate: 32.8%), so the final reaction could not be performed.
Claims
1. (a) a step of oxidizing 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propionic acid methyl ester of the structural formula P-3 below with a hydrate of hypochlorite and an N-oxyl oxidation catalyst in the presence of an organic solvent; and (b) a step of treating the reaction product obtained in the above step (a) with benzene sulfonic acid in an organic solvent; A method for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]-benzodiazepin-4-yl]propionic acid methyl ester benzenesulfonate, which is a remimazolam besylate having the following structural formula P: [P-3] [P] 2. A manufacturing method according to claim 1, characterized in that the hydrate of the hypochlorite is at least one selected from the group consisting of a hydrate of sodium hypochlorite (NaOCl), a hydrate of potassium hypochlorite (KOCl), and a hydrate of calcium hypochlorite (Ca(OCl)2).
3. A manufacturing method according to claim 1, characterized in that the hydrate of the hypochlorite is sodium hypochlorite pentahydrate (NaOCl·5H2O).
4. A manufacturing method according to claim 1, characterized in that the hypochlorite hydrate is used in an equivalent ratio of 0.1 to 5 with respect to the compound of structural formula P-3.
5. In the first paragraph, the N-oxyl oxidation catalyst is characterized in that it is at least one selected from the group consisting of 2-azaadamantane-N-oxyl (AZADO) represented by the structural formula 1 below, 1-methyl-2-azaadamantane-N-oxyl (Me-AZADO) represented by the structural formula 2 below, 2-hydroxy-2-azaadamantane (AZADOH) represented by the structural formula 3 below, 2,2,6,6,-tetramethylpiperidine N-oxyl (TEMPO) represented by the structural formula 4 below, and 9-azabicyclo-[3.3.1]nonane-N-oxyl (ABNO) represented by the structural formula 5 below, salts thereof, and solvates thereof. [Structural formula 1] [Structural formula 2] [Structural formula 3] [Structural formula 4] [Structural formula 5] 6. A manufacturing method according to claim 1, characterized in that the N-oxyl oxidation catalyst is used in an equivalent ratio of 0.01 to 0.2 with respect to the compound of structural formula P-3.
7. A manufacturing method characterized in that, in step (a), an ammonium salt is additionally used.
8. A manufacturing method according to claim 7, characterized in that the ammonium salt is at least one selected from the group consisting of tetrabutylammonium bromide (TBAB), tetrabutylammonium fluoride (TBAF), tetrabutylammonium chloride (TBAC), tetrabutylammonium iodide (TBAI), salts thereof, and solvates thereof.
9. A manufacturing method according to claim 7, characterized in that the ammonium salt is used in an equivalent ratio of 0.01 to 0.5 with respect to the compound of structural formula P-3.
10. A manufacturing method according to claim 1, characterized in that an inorganic oxidizing agent is additionally used in step (a).
11. A manufacturing method according to claim 10, characterized in that the inorganic oxidizing agent is at least one selected from the group consisting of OXONE (2KHSO5.KHSO4.K2SO4), salts thereof, and solvates thereof.
12. A manufacturing method according to claim 10, characterized in that the inorganic oxidizing agent is not used or is used in an equivalent ratio of 0.01 to 3 for the compound of structural formula P-3.
13. A manufacturing method characterized in that, in step (a), an alkaline earth metal peroxide is additionally used.
14. A manufacturing method according to claim 13, characterized in that the alkaline earth metal peroxide is at least one selected from the group consisting of calcium peroxide (CaO2), magnesium peroxide (MgO2), salts thereof, and solvates thereof.
15. A manufacturing method according to claim 13, characterized in that the peroxide of an alkaline earth metal is not used or is used in an equivalent ratio of 0.01 to 0.5 with respect to the compound of structural formula P-3.
16. A manufacturing method according to any one of claims 1 to 15, wherein the organic solvent used in step (a) is selected from ethyl acetate, methyl acetate, methylene chloride, dichloroethane, toluene, acetone, diethyl ether, methyl tert-butyl ether, pentane, hexane, acetonitrile, tetrahydrofuran and mixtures thereof.
17. A manufacturing method characterized in that, in any one of claims 1 to 15, after the oxidation reaction of step (a) is carried out at a conversion rate of 98% or more, the reaction solution is worked up and step (b) is carried out with the obtained product.
18. A manufacturing method according to claim 17, characterized in that the oxidation reaction of step (a) proceeds within 15 to 180 minutes.
19. A manufacturing method according to any one of claims 1 to 15, characterized in that the oxidation reaction of step (a) is performed within a range of 0 to 30°C.
20. A manufacturing method according to any one of claims 1 to 15, characterized in that in step (b), the organic solvent is selected from the group consisting of ethyl acetate, methyl acetate, methanol, ethanol, methyl ethyl ketone, and mixtures thereof.
21. A manufacturing method according to any one of claims 1 to 15, characterized in that in step (b), benzene sulfonic acid is used in an amount of 0.9 to 1.1 equivalents with respect to the compound of structural formula P-3.
Citation Information
Patent Citations
A method for preparing a benzodiazepine drug
CN112321594B
Bromine free tempo based catalyst system for oxidationof primary and secondary alcohols using naocl as anoxidant
KR101162648B1
PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZOL[ 1,2-a][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF AND COMPOUNDS USEFUL IN THAT PROCESS
KR101801735B1
Preparation method of benzodiazepine drugs
CN112321594A
PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZOL[ 1,2-a][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF AND COMPOUNDS USEFUL IN THAT PROCESS
KR1020120102603A
